Semler Scientific (NASDAQ:SMLR) Sees Strong Trading Volume – Here’s What Happened

Semler Scientific, Inc. (NASDAQ:SMLRGet Free Report) saw unusually-strong trading volume on Friday . Approximately 149,046 shares were traded during mid-day trading, a decline of 42% from the previous session’s volume of 257,789 shares.The stock last traded at $62.10 and had previously closed at $61.05.

Semler Scientific Stock Performance

The stock’s 50 day moving average is $35.16 and its 200 day moving average is $31.74. The company has a market capitalization of $487.87 million, a PE ratio of 29.78 and a beta of 0.92.

Semler Scientific (NASDAQ:SMLRGet Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35. The business had revenue of $13.51 million for the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Institutional Trading of Semler Scientific

A number of hedge funds and other institutional investors have recently bought and sold shares of SMLR. State Street Corp increased its holdings in shares of Semler Scientific by 0.6% in the third quarter. State Street Corp now owns 118,223 shares of the company’s stock worth $2,784,000 after purchasing an additional 725 shares during the period. CWM LLC raised its holdings in shares of Semler Scientific by 486.3% in the 2nd quarter. CWM LLC now owns 897 shares of the company’s stock valued at $31,000 after acquiring an additional 744 shares in the last quarter. Quest Partners LLC boosted its position in shares of Semler Scientific by 48.0% during the 3rd quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock valued at $59,000 after acquiring an additional 817 shares during the last quarter. Newbridge Financial Services Group Inc. purchased a new position in shares of Semler Scientific during the second quarter worth about $34,000. Finally, US Bancorp DE increased its position in shares of Semler Scientific by 60.8% in the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock worth $72,000 after purchasing an additional 1,158 shares during the last quarter. Institutional investors own 49.37% of the company’s stock.

About Semler Scientific

(Get Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.

Featured Stories

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.